S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.Rui‐Hua Xu, Qingfeng Zou, Lin Shen et al.|Journal of Clinical Oncology|2019Cited by 24